drugset / Trial / NCT05240274

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

NCT05240274 ↗

Phase 2 Completed 60 enrolled Barts & The London NHS Trust
RandomizedParallel-groupQuadruple-blindPrevention

Summary

PrOphylaxis With mEtformin to pREvent PTDM: a single site, placebo controlled, double blind randomised clinical trial evaluating the effectiveness of metformin to prevent post-transplant diabetes in a cohort of patients undergoing renal transplantation.

Timeline

Start
2019-01-25
Primary completion
2022-05-30
Completion
2022-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg —